Latest
July’s 0.7% monthly gain did not turn the three-month trend positive, while output was unchanged from a year earlier. Pharmaceuticals and energy are advancing, but the wider manufacturing recovery still lacks breadth.
ReadFuel hedges can postpone the effect of the latest oil shock, but they cannot remove it. The eventual pressure on margins will reveal whether European airlines can raise unit revenue without sacrificing demand.
Belron’s value rests on insurer access, network density and the technical demands of ADAS recalibration rather than on glass alone. A possible Amsterdam listing would give Europe a rare large scale service asset, but leverage and disclosure quality will shape the valuation.
Europe’s renewed energy shock is now raising both operating costs and financing costs. The most vulnerable companies are those where weak pricing power, short hedges and refinancing needs occur together.
Europe still trades below the United States, but sector mix, weaker growth and lower reinvestment returns explain much of the gap. The rerating has removed the case for treating the region as uniformly cheap.
Independent analysis of the companies compounding in Europe.
The work is fundamental: business quality, capital allocation and valuation, read from the filings rather than from broker models or press coverage.
It is written for a multi-year horizon — for investors who hold for years rather than quarters — and published when the work is finished rather than on a calendar.
No sponsored coverage, no paid placements and no banking relationships sit behind any of it, and every piece names the evidence that would prove it wrong.